alpha62539

PFE set for a rebound

Long
alpha62539 Updated   
NYSE:PFE   Pfizer
PFE beat analysts' estimates on EPS but provided an outlook that didn`t meet expectations. However, The Co expects revenues to grow by 7-9% in 2023. Considering its plans to boost business by acquiring SGEN, the current market cap looks attractive as a reverse to mean play and a fundamentally driven long-term investment case.
Trade closed: stop reached:
Stop reached, if the price goes again above 41 I will be a buyer.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.